Offline mode

17ß-Estradiol Saliva Luminescence Immunoassay

Catalog no.RE62141
Regulatory Status
IVD
Kit size
12 x 8
Method
Luminescence Immunoassay
Incubation time
1 x 4 h; 1 x 10 min
Standard range
0.9 - 64 pg/mL
Specimen / Volumes
50 µL Saliva
Substrate / isotope
Acridinium based
instructions for usecertificateMSDS
product information downloads

Luminescence immunoassay for the in-vitro-diagnostic quantitative determination of 17beta-Estradiol in human saliva.

The 17beta-Estradiol Saliva Luminescence Immunoassay is intended for the measurement of 17-betaEstradiol in human saliva. Estradiol is the most important natural estrogen and present in both women and men. The measurement of the hormone level is useful for detection of estrogen deficiency. Estradiol has an impact on puberty, primary and secondary amenorrhea and menopause. This test is not intended for assessing placental function in complicated pregnancy.

Additional hormone assays are recommended for an interpretation of the estradiol level. The 17beta-Estradiol Saliva Luminescence Immunoassay is based on the competition principle and measured on a microtiterplate luminescence reader. The assay is semi-automated requiring general purpose laboratory instruments and consumables such as luminescence microplate reader/washer, vortexer and pipettes to execute the test. Test results may be calculated manually from a standard curve and compared to laboratory established reference ranges from healthy adults (i.e. normal ranges).

The test kit is intended for professional laboratory use by trained personnel. The test kit is not for home or layperson use. The test kit is intended for manual use.

For concrete data please consult the Instruction for Use in the download box on the top right side.

[1] Ryan, K. J. (1982). Biochemistry of aromatase: significance to female reproductive physiology. Cancer research, 42(8 Supplement), 3342s-3344s.

[2] Greenspan, F. S., & Gardner, D. G. (2001). Basic and clinical endocrinology.

[3] Gavrilova, N., & Lindau, S. T. (2009). Salivary sex hormone measurement in a national, populationbased study of older adults. Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 64(suppl_1), i94-i105.

[4] Mendoza, K., Curran, M., Salimetrics, L. L. C., & Lindau, S. T. (2007). Salivary Estradiol Measurement in Wave I of the Social Life Health & Aging Project. J Gerontol B Psychol Sci Soc Sci. 2009 Nov; 64B(Suppl 1): i94–i105. doi: 10.1093/geronb/gbn028

[5] Tivis, L. J., Richardson, M. D., Peddi, E., & Arjmandi, B. (2005). Saliva versus serum estradiol: implications for research studies using postmenopausal women. Progress in NeuroPsychopharmacology and Biological Psychiatry, 29(5), 727-732.

[6] Jameson JL, De Groot LJ (25 February 2015). Endocrinology: Adult and Pediatric E-Book. Elsevier Health Sciences. p. 2179. ISBN 978-0-323-32195-2.

[7] Shirtcliff, E. A., Dahl, R. E., & Pollak, S. D. (2009). Pubertal development: correspondence between hormonal and physical development. Child development, 80(2), 327-337.

[8] Fernández-Garcia, B., Lucia, A., Hoyos, J., Chicharro, J. L., Rodriguez-Alonso, M., Bandres, F., & Terrados, N. (2002). The response of sexual and stress hormones of male pro-cyclists during continuous intense competition. International journal of sports medicine, 23(08), 555-560.

[9] Ikegami, S., Moriwake, T., Tanaka, H., Inoue, M., Kubo, T., Suzuki, S., ... & Seino, Y. (2001). An ultrasensitive assay revealed age‐related changes in serum oestradiol at low concentrations in both sexes from infancy to puberty. Clinical endocrinology, 55(6), 789-795.

[10] Kang, J. Y., Park, J. Y., Chun, S. I., Suh, H. S., Lee, K., & Ahn, R. S. (2014). Puberty-related changes in cortisol, dehydroepiandrosterone, and estradiol-17β secretions within the first hour after waking in premenarcheal girls. Neuroendocrinology, 99(3-4), 168-177.

[11] McIver, B., Romanski, S. A., & Nippoldt, T. B. (1997, December). Evaluation and management of amenorrhea. In Mayo Clinic Proceedings (Vol. 72, No. 12, pp. 1161-1169). Elsevier.

[12] Buckler, H. (2005). The menopause transition: endocrine changes and clinical symptoms. British Menopause Society Journal, 11(2), 61-65.

[13] Goletiani, N. V., Keith, D. R., & Gorsky, S. J. (2007). Progesterone: Review of safety for clinical studies. Experimental and clinical psychopharmacology, 15(5), 427.

[14] Bowen R (2000-08-06). "Placental Hormones". Retrieved 2020-29-12. http://www.vivo.colostate.edu/hbooks/pathphys/reprod/placenta/endocrine.html

[15] Hall, J. E. (2004). Neuroendocrine control of the menstrual cycle. In J. F. Strauss, III, & R. L. Barbieri (Eds.), Yen and Jaffe’s reproductive endocrinology: Physiology, pathophysiology, and clinical management (5th ed., pp. 195–211). Philadelphia: Elsevier [16] Cable, J. K., & Grider, M. H. (2020). Physiology, Progesterone. StatPearls

[17] Frank, G. R. (2003). Role of estrogen and androgen in pubertal skeletal physiology. Medical and pediatric oncology, 41(3), 217-221.

[18] Herrera et al., 2017: Herrera, A. Y., Hodis, H. N., Mack, W. J., & Mather, M. (2017). Estradiol therapy after menopause mitigates effects of stress on cortisol and working memory. The Journal of Clinical Endocrinology & Metabolism, 102(12), 4457-4466

[19] Vermeulen, A., Kaufman, J. M., Goemaere, S., & Van Pottelberg, I. (2002). Estradiol in elderly men. The aging male, 5(2), 98-102. [20] Dielen, C., Fiers, T., Somers, S., Deschepper, E., & Gerris, J. (2017). Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI. Facts, views & vision in ObGyn, 9(2), 85.

[21] Lu, Y. C., Bentley, G. R., Gann, P. H., Hodges, K. R., & Chatterton, R. T. (1999). Salivary estradiol and progesterone levels in conception and nonconception cycles in women: evaluation of a new assay for salivary estradiol. Fertility and sterility, 71(5), 863-868.

[22] Bacon, J. L. (2017). The menopausal transition. Obstetrics and Gynecology Clinics, 44(2), 285-296.

[23] Gandara, B. K., Leresche, L., & Mancl, L. (2007). Patterns of salivary estradiol and progesterone across the menstrual cycle. Annals of the New York Academy of Sciences, 1098, 446.

[24] Schmidt, J., Wenzel, F., & Blessing, F. (2020) Practical evaluation of two commercial immunoassays for the quantification of steroid hormones in human saliva. Journal of Cellular Biotechnology, (Preprint), 1-9.

25] Shirtcliff, E. A., D. A. Granger, et al. (2000). "Assessing estradiol in biobehavioral studies using saliva and blood spots: simple radioimmunoassay protocols, reliability, and comparative validity." Horm Behav 38(2): 137-47

[26] Quaiser‐Pohl, C., Jansen, P., Lehmann, J., & Kudielka, B. M. (2016). Is there a relationship between the performance in a chronometric mental‐rotations test and salivary testosterone and estradiol levels in children aged 9–14 years?. Developmental psychobiology, 58(1), 120-128.

[27] Choe, J. K., Khan-Dawood, F. S., & Yusoff-Dawood, M. (1983). Progesterone and estradiol in the saliva and plasma during the menstrual cycle. American journal of obstetrics and gynecology, 147(5), 557-562

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.